0001209191-16-127022.txt : 20160610 0001209191-16-127022.hdr.sgml : 20160610 20160610150936 ACCESSION NUMBER: 0001209191-16-127022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160608 FILED AS OF DATE: 20160610 DATE AS OF CHANGE: 20160610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 161708453 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-08 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2016-06-08 4 M 0 5130 35.35 A 273355 D Common Stock 2016-06-08 4 S 0 4930 94.93 D 268425 D Common Stock 2016-06-08 4 S 0 200 95.57 D 268225 D Common Stock 13286 I 401k Common Stock 122700 I Common Stock Held In Trust Stock Option (Right to Buy) 35.35 2016-06-08 4 M 0 5130 0.00 D 2016-07-19 Common Stock 5130 25660 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $94.93 (range $94.41 to $95.40). Open market sales reported on this line occurred at a weighted average price of $95.57 (range $95.56 to $95.57). Fully vested. Michael LaCascia, Attorney-In-Fact 2016-06-10